학술논문

Novel combinatorial therapy of oncolytic adenovirus AdV5/3-D24-ICOSL-CD40L with anti PD-1 exhibits enhanced anti-cancer efficacy through promotion of intratumoral T-cell infiltration and modulation of tumour microenvironment in mesothelioma mouse model
Document Type
Article
Source
In: Frontiers in Oncology. (Frontiers in Oncology, 2023, 13)
Subject
Language
English
ISSN
2234943X